Skin Substitutes: Past, Present, and Future

Charles E. Butler

doi:10.1055/s-2003-39861

Seminars in Plastic Surgery, Table of Contents

Semin Plast Surg 2003; 17(1): 107-118
DOI: 10.1055/s-2003-39861

Skin Substitutes: Past, Present, and Future

Charles E. Butler

Department of Plastic Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Abstract

ABSTRACT

Enormous advances in the development of skin substitutes have occurred over the past 3 decades. There are numerous commercially available skin substitutes, some of which can provide permanent dermis or epidermis. Unfortunately, no product available can permanently replace both dermis and epidermis in a single-stage application procedure. Several investigators have reported promising strategies for permanent skin replacement using a wide variety of components and culturing techniques. Obstacles to overcome in the quest for an ideal skin substitute include epidermal antigenicity, scarring, contraction, pigmentation, and loss of adnexal structures. The development, indications, and shortcomings of several currently used skin substitutes and promising experimental strategies are reviewed. The future direction of tissue-engineered skin substitutes is addressed with a focus on overcoming the current obstacles.

KEYWORDS

Skin substitutes - skin - keratinocytes - artificial skin - review

Full Text

References

REFERENCES

1 Asmursen P. The Skin. Einfurung and Grundlage: Rohstoffe, Klebetchnologie, vol 1. Compendium Medical; 1986
2 Mast B A. The skin. In: Cohen IK, Diegelmann RF, Lindbald WJ, eds. Wound Healing: Biochemical and Clinical Aspects Philadelphia, PA: WB Saunders 1992: 344-355
3 Boyce S. Design principles for composition and performance of cultured skin substitutes. Burns . 2001; 27 523-533
4 Bello Y, Falabella A. Use of skin substitutes in dermatology. Dermatol Clin . 2001; 19 555-560
5 Muller M J, Nicolai O, Wiggins R. In: Herndon D, ed. Total Burn Care. London: WB Saunders 1996: 1827-1829
6 Schulz J, Tompkins R. Artificial skin. Annu Rev Med . 2000; 51 231-244
7 Greenfield E, Jordan B. Advances in burn wound care. Crit Care Nurs Clin North Am . 1996; 8 203-215
8 Sheridan R, Tompkins R. Skin substitutes in burns. Burns . 1999; 25 97-103
9 Eaglstein W, Falanga V. Tissue engineering and the development of Apligraf(r), a human skin equivalent. Adv Wound Care . 1998; 11(4 suppl) 1-8
10 Balasubramani M, Kumar T. Skin substitutes: a review. Burns . 2001; 27 534-544
11 Bello Y, Falabella A. Tissue-engineered skin: current status in wound healing. Am J Clin Dermatol . 2001; 2 305-313
12 Pomahac;ak B, Svenjö T. Tissue engineering of skin. Crit Rev Oral Biol Med . 1998; 9 333-344
13 Phillips T. New skin for old: developments in biological skin substitutes. Arch Dermatol . 1998; 134 344-349
14 Arons J, Wainwright D, Jordon R. The surgical applications and implications of cultured human epidermis: a comprehensive review. Surgery . 1992; 111 4-11
15 Rheinwald J, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell . 1975; 6 331-344
16 Rheinwald J, Green H. Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell . 1975; 6 317-330
17 Green H, Kehinde O. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA . 1979; 76 5665-5668
18 Woodley D. Covering wounds with cultured keratinocytes. JAMA . 1989; 262 2140-2141
19 O'Connor N, Mulliken J. Grafting of burns with cultured epithelium from autologous epidermal cells. Lancet . 1981; 1 75-78
20 Gallico G, O'Connor N. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med . 1984; 311 448-451
21 Woodley D, Peterson H. Burn wounds resurfaced by cultured epidermal autografts show abnormal reconstitution of anchoring fibrils. JAMA . 1988; 259 2566-2571
22 Hafemann B, Ensslen S, Erdmann C. Use of collagen/ elastin membrane for the tissue engineering dermis. Burns . 1999; 25 373-384
23 Bergstresser H, Baxter C. Composite skin grafts: frozen dermal allografts support the engraftment and expansion of autologous epidermis. J Trauma . 1985; 25 106-112
24 Cuono C, Langdon R, McGuire J. Use of cultured epidermal autografts and dermal allografts as skin replacements after burn injury. Lancet . 1986; 1 1123-1124
25 Compton C, Hickerson W, Nadire K. Acceleration of skin regeneration from cultured epithelial autografts by transplantation to homograft dermis. J Burn Care Rehab . 1993; 14 653-662
26 Kraut J, Eckhardt A, Patton M. Combined simultaneous application of cultured epithelial autografts and Alloderm(r). Wounds . 1995; 7 137-142
27 Orgill D, Butler C, Regan J. A vascularized collagen-gag matrix provides a dermal substrate and improves take of cultured epithelial autografts. Plast Reconstr Surg . 1998; 102 423-429
28 Hundyadi J, Farkas B, Bertenyi C. Keratinocyte grafting: new means of transplantation for full-thickness wounds. J Dermatol Surg Oncol . 1988; 14 75
29 Kaiser H, Stark G, Kopp J. Cultured autologous keratinocytes in fibrin glue suspension, exclusively and combined with STS-allograft (preliminary clinical and histological report of a new technique). Burns . 1994; 20 23
30 Hafemann B, Hettich R, Ensslen S. Treatment of skin defects using suspensions of in vitro cultured keratinocytes. Burns . 1994; 20 68
31 Horch R, Bannasch H, Kopp J. Single-cell suspensions of cultured human keratinocytes in fibrin-glue reconstitute the epidermis. Cell Transplant . 1995; 7 309
32 Alsbjörn B. Biologic wound coverings in burn treatment. World J Surg . 1992; 16 43-46
33 Hefton J, Ambershon J, Bizes D. Loss of HLA DR expression by human epidermal cells after growth in culture. J Invest Dermatol . 1984; 83 48-50
34 Thiovlet J, Faure M, Demidem A. Long term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation . 1986; 42 274-280
35 Aubock J, Irschick E, Romani N. Rejection, after a slightly prolonged survival time, of Langerhans cell-free allogeneic cultured epidermis used for wound coverage in humans. Transplantation . 1988; 45 730-737
36 Brain A, Purkis P, Coates P. Survival of cultured allogeneic keratinocytes transplanted to a deep dermal bed assessed with a probe specific for Y chromosome. Br Med J . 1989; 298 917-919
37 Burt A, Pallet C, Sloane J. Survival of cultured allografts in patients with burns assessed with a probe specific for Y chromosome. Br Med J . 1989; 298 915-917
38 Phillips T. Biologic skin substitutes. J Dermatol Surg Oncol . 1992; 19 794-800
39 Bolivar-Flores J, Poumian E, Marsch-Moreno M. Use of cultured human epidermal keratinocytes for allografting burns and conditions for temporary banking of the cultured allografts. Burns . 1990; 16 3-8
40 Larochelle F, Ross G, Rouabhia M. Permanent skin replacement using engineered epidermis containing fewer than 5% syngeneic keratinocytes. Lab Invest . 1998; 78 1089-1099
41 Burke J, Yannas I, Quinby W. Successful use of physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg . 1981; 194 413-428
42 Yannas I, Burke J. Design of an artificial skin. I. Design principles. J Biomed Mater Res . 1980; 14 65-68
43 Yannas I, Burke J, Gordon P. Design of an artificial skin. III. Control of chemical composition. J Biomed Mater Res . 1980; 14 107-113
44 Orgill D, Butler C, Regan J. Behavior of collagen-GAG matrices as dermal replacement in rodent and porcine models. Wounds . 1996; 8 151-157
45 Wainwright D. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns . 1995; 21 243-248
46 Wainwright D, Madden M, Luterman A. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehab . 1996; 17 124-136
47 Munster A, Smith-Meek M, Shalom A. Acellular allograft dermal matrix: immediate or delayed epidermal coverage?. Burns . 2000; 27 150-153
48 Cooper M, Hansbrough J, Spielvogel R. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials . 1991; 12 243-248
49 Hansbrough J, Cooper M, Cohen R. Evaluation of a biodegradable matrix containing cultured human fibroblasts as a dermal replacement beneath meshed skin grafts on athymic mice. Surgery . 1992; 111 438-445
50 Hansbrough J, Dore C, Hansbrough W. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehab . 1992; 13 519-529
51 Gentzkow G, Iwasaki S, Hershon K. Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care . 1996; 19 350-354
52 Bell E, Ehrlich P, Buttle D. Living tissue formed in vitro and accepted as skin-equivalent of full-thickness. Science . 1981; 221 1052-1054
53 Kearney J. Clinical evaluation of skin substitutes. Burns . 2001; 27 545-551
54 Wilkins L, Watson S, Prosky S. Development of a bi-layered living skin construct for clinical applications. Biotechnol Bioeng . 1994; 43 747-756
55 Falanga V, Margolis D, Alvarez O. Healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol . 1998; 134 293-300
56 Trent J, Kirsner R. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent. Int J Clin Pract . 1998; 52 408-413
57 Eaglstein W, Iriondo M, Laszlo K. A composite skin substitute (Graftskin) for surgical wounds. Dermatol Surg . 1995; 21 839-843
58 Muhart M, McFalls S, Kersner R. Bioengineered skin. Lancet . 1997; 350 1142
59 Falabella A, Valencia I, Eaglstein W. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol . 2000; 136 1225-1230
60 Kirsner R. The use of Apligraf(r) in acute wounds. J Dermatol . 1998; 25 805-811
61 Boyce S, Kagan R, Meyer N. Cultured skin substitutes combined with Integra to replace native skin autograft and allograft for closure of full-thickness burns (abstract). J Burn Care Rehab . 1999; 20 S196
62 Lam P, Chan E, To E. Development and evaluation of a new composite Laserskin graft. J Trauma . 1999; 47 918
63 Butler C. Autologous keratinocyte derived skin substitutes. Paper presented at the Plastic Surgery Research Council Meeting, April 20, 2002, Boston, MA
64 Butler C. Strategies of artificial skin development. Artificial skin and tissue engineering symposium. Paper presented at the annual meeting of the American Society of Plastic Surgeons, November 7, 2001, Orlando, FL
65 Butler C, Orgill D, Compton C. The effect of keratinocyte seeding of collagen-glycosaminoglycan membranes on the regeneration of skin in a porcine model. Plast Reconstr Surg . 1998; 101 1572-1579
66 Butler C, Orgill D, Compton C. Effects of cell culturing on keratinocyte-seeded collagen-glycosaminoglycan matrix skin replacement in full-thickness porcine wounds. Surg Forum . 1996; 47 752-754
67 Butler C, Orgill D, Correia C. Comparison of cultured and uncultured keratinocytes used for cell seeded collagen-GAG matrix skin replacements. Br J Plast Surg . 1999; 52 127-132
68 Compton C, Butler C, Yannas I. Organized skin structure is regenerated in vivo from collagen-GAG matrices seeded with autologous keratinocytes. J Invest Dermatol . 1998; 110 908-916
69 Butler C, Navarro F, Park C. Regeneration of neomucosa using cell-seeded collagen-GAG matrices in athymic mice. Ann Plast Surg . 2002; 48 298-304
70 Butler C, Orgill D. Autologous keratinocytes combined with a collagen-GAG matrix. In: Horch RE, ed.Cultured Human Keratinocytes and Tissue Engineered Skin Substitutes New York: Thieme Medical Publishers; 2001: 243-250
71 Jones P, Watt F. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in Integrin(r) function and expression. Cell . 1993; 73 713-724
72 Berthod F, Damour O. In vitro reconstructed skin models for wound coverage in deep burns. Br J Dermatol . 1997; 136 809-816
73 Mulligan R. The basic science of gene therapy. Science . 1993; 260 926
74 Andree C, Voigt M, Wenger A. Plasmid gene delivery to human keratinocytes through a fibrin-mediated transfection system. Tissue Eng . 2001; 7 757-766
75 Supp D, Supp A, Bell S. Enhanced vascularization of cultured skin substitutes genetically modified to overexpression vascular endothelial growth factor. J Invest Dermatol . 2000; 114 5-13
76 Dellambra E, Vailly J, Pellegrini G. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa. Hum Gene Ther . 1998; 9 1359-1370
77 De Luca M, Franzi A, D'Anna F. Coculture of human keratinocytes and melanocytes: differentiated melanocytes are physiologically organized in the basal layer of the cultured epithelium. Eur J Cell Biol . 1988; 46 176-180
78 De Luca M, D'Anna F, Bondanza S. Human epithelial cells induce human melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. J Cell Biol . 1988; 107 1919-1926
79 De Luca M, Bondanza S, DiMarco E. et al .Keratinocyte-melanocyte interactions in in vitro reconstituted normal human epidermis. In: Leigh I. Lane, B. Watt, F. eds. The Keratinocyte Handbook Cambridge UK: Cambridge University Press 1994: 95-108
80 Nakazawa K, Sahuc F, Collombel C. et al . Pigmented human skin equivalent as a model of the mechanisms of control of cell-cell cell-matrix interactions. Med Biol Eng Comput . 1998; 36 813-820
81 Guerra L, Capurro S, Melchi M. et al . Treatment of "stable" vitiligo by Timed surgery transplantation of cultured epidermal autografts. Arch Dermatol . 2000; 136 1380-1389